Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.
The Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter
|3||2||Johnson & Johnson||3,281||431||67|
|8||4||Merck & Co||337||273||25|
|42||41||Mitsubishi Tanabe Pharma||1||1||1|
The latest insights from HCPs mentioning the Top 50 Pharmaceutical Companies
The five pharmaceutical companies that were mentioned the most by healthcare professionals (HCPs) on Twitter during December 2021 were Pfizer, AstraZeneca, Johnson & Johnson, GSK and Regeneron.
COVID-19 news, especially regarding the vaccine, continued to drive conversations about the Top 50 Pharmaceutical companies in December. Pfizer, as in previous months, remained at the top of discussions this month, with conversations about protection against the Omicron variant and the sharing of trial data regarding the efficacy of the Pfizer vaccine. Pfizer received six times as many mentions as the next company (AstraZeneca).
💡New VACCINE RANKING of ability to neutralize #Omicron—Moderna appears to be the strongest against Omicron in this study, but still big drop. Pfizer next best (but we know infection efficacy is 30-34%), AstraZeneca & Sinopharm poor. J&J & Sputnik = zero.🧵https://t.co/5xmnXH2XaJ pic.twitter.com/eZq8jbMEsQ
— Eric Feigl-Ding (@DrEricDing) December 15, 2021
The most shared links by HCPs were about the usefulness of the Pfizer vaccine against the new Omicron variant:
- Study results produced by Alex Sigal of Sigal Lab regarding the neutralization of Omicron using the Pfizer vaccine.
- A press release by Pfizer about the ability of its vaccine to neutralize Omicron.
- Study results regarding T cell responses against Omicron.
COVID-19 made up 70% of the conversations from HCPs about Top 50 Pharmaceutical companies. This was mostly impacted by the Omicron variant and HCP’s discussion of the protection offered by the COVID vaccines against this new variant.
In December 2021, Regeneron climbed into the top five most talked about pharmaceutical companies due to news about their monoclonal antibodies ineffectiveness against the Omicron variant. HCP conversation ranged from simply sharing the information surrounding the monoclonal antibodies to frustration about the unavailability of the antibodies given the severity of the pandemic.
Bad news: The MAbs that your hospital has stocked (likely Regeneron or Lilly) no longer work against Omicron. The one that will work (GSK's Sotrovimab) is in massively short supply. Moreover, lab tests show some loss in GSK's efficacy as well. https://t.co/ttSzlhfHn7.(10/25)
— Bob Wachter (@Bob_Wachter) December 22, 2021
Eh @GavinNewsom pay attention 👇👇 DRS NEED MONOCLONAL abs from @Regeneron in their offices STAT !! Release them . WHY is there a limit on supplies. Cases are climbing like in NY regardless of your mandates. Release treatment NOW !!! First HCQ , then IVM now monoclonal abs. https://t.co/IFhWpBJRv8
— sabine hazan md (@SabinehazanMD) December 18, 2021
CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.
To stay up to date, you can sign up to CREATION.co’s monthly eJournal.
- In December 2021, CREATION Pinpoint® identified 35,141 healthcare professional (HCP) authored tweets from 12,497 individual HCPs mentioning a Top 50 Pharmaceutical company (according to revenue).
- Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 Pharmaceutical company between December 1st and December 31st 2021.
- Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
- In some cases, a tweet may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
- Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In December 687 of these posts mentioned Janssen.